GT Medical Technologies Completes $100 Million Series E to Advance GammaTile in Operable Brain Tumors
GT Medical Technologies Completes $100 Million Series E to Advance GammaTile in Operable Brain Tumors
Posts
FDA Places Clinical Holds on Regenxbio's RGX-111 and RGX-121 Gene Therapy Trials After Brain Tumor in Patient
FDA Places Clinical Holds on Regenxbio's RGX-111 and RGX-121 Gene Therapy Trials After Brain Tumor in Patient
- Get link
- X
- Other Apps
Rakovina Therapeutics Showcases Compelling Preclinical Data on AI-Discovered CNS-Penetrant ATR/mTOR Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
Rakovina Therapeutics Showcases Compelling Preclinical Data on AI-Discovered CNS-Penetrant ATR/mTOR Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
- Get link
- X
- Other Apps
FDA Grants Accelerated Approval to Jazz's Dordaviprone (Modeyso), the First Treatment for Ultra-Rare Brain Tumor
FDA Grants Accelerated Approval to Jazz's Dordaviprone (Modeyso), the First Treatment for Ultra-Rare Brain Tumor
- Get link
- X
- Other Apps
Jazz Pharmaceuticals to Acquire Chimerix for $935 Million, Gaining Promising Brain Tumor Drug Dordaviprone
Jazz Pharmaceuticals to Acquire Chimerix for $935 Million, Gaining Promising Brain Tumor Drug Dordaviprone
- Get link
- X
- Other Apps